Atara Biotherapeutics, Inc. (ATRA)

Atara Biotherapeutics Statistics

Total Valuation

ATRA has a market cap or net worth of $38.26 million. The enterprise value is $41.19 million.

Market Cap	38.26M
Enterprise Value	41.19M

Important Dates

The last earnings date was Friday, March 7, 2025, after market close.

Earnings Date	Mar 7, 2025
Ex-Dividend Date	n/a

Share Statistics

ATRA has 5.86 million shares outstanding. The number of shares has increased by 76.77% in one year.

Current Share Class	5.86M
Shares Outstanding	5.86M
Shares Change (YoY)	+76.77%
Shares Change (QoQ)	+43.45%
Owned by Insiders (%)	2.25%
Owned by Institutions (%)	43.79%
Float	4.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.38
Forward PS	0.91
PB Ratio	-0.39
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.32
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.48

Current Ratio	0.48
Quick Ratio	0.33
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.97

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-35.66%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	307.47%
Revenue Per Employee	$842,745
Profits Per Employee	-$558,190
Employee Count	153
Asset Turnover	0.94
Inventory Turnover	16.58

Taxes

Income Tax	-12,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.69% in the last 52 weeks. The beta is 0.49, so ATRA's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	-62.69%
50-Day Moving Average	7.58
200-Day Moving Average	9.36
Relative Strength Index (RSI)	40.98
Average Volume (20 Days)	53,196

Short Selling Information

The latest short interest is 723,264, so 12.34% of the outstanding shares have been sold short.

Short Interest	723,264
Short Previous Month	715,084
Short % of Shares Out	12.34%
Short % of Float	17.21%
Short Ratio (days to cover)	10.33

Income Statement

In the last 12 months, ATRA had revenue of $128.94 million and -$85.40 million in losses. Loss per share was -$11.41.

Revenue	128.94M
Gross Profit	-39.80M
Operating Income	-78.33M
Pretax Income	-233.09M
Net Income	-85.40M
EBITDA	-73.28M
EBIT	-78.33M
Loss Per Share	-$11.41

Balance Sheet

The company has $42.50 million in cash and $45.43 million in debt, giving a net cash position of -$2.94 million or -$0.50 per share.

Cash & Cash Equivalents	42.50M
Total Debt	45.43M
Net Cash	-2.94M
Net Cash Per Share	-$0.50
Equity (Book Value)	-97.28M
Book Value Per Share	-16.60
Working Capital	-69.68M

Cash Flow

In the last 12 months, operating cash flow was -$68.72 million and capital expenditures -$246,000, giving a free cash flow of -$68.96 million.

Operating Cash Flow	-68.72M
Capital Expenditures	-246,000
Free Cash Flow	-68.96M
FCF Per Share	-$11.77

Margins

Gross margin is -30.87%, with operating and profit margins of -60.75% and -66.23%.

Gross Margin	-30.87%
Operating Margin	-60.75%
Pretax Margin	-66.24%
Profit Margin	-66.23%
EBITDA Margin	-56.83%
EBIT Margin	-60.75%
FCF Margin	n/a

Dividends & Yields

ATRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-76.77%
Shareholder Yield	n/a
Earnings Yield	-223.23%
FCF Yield	-180.25%

Analyst Forecast

The average price target for ATRA is $25.70, which is 293.57% higher than the current price. The consensus rating is "Buy".

Price Target	$25.70
Price Target Difference	293.57%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	8.15%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on June 20, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Jun 20, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

ATRA has an Altman Z-Score of -28.14 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-28.14
Piotroski F-Score	3